RT @ProvectusBio: 6b/ [2] Thompson JF et al. Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma. Ann Surg Oncol. 2015 J…
6b/ [2] Thompson JF et al. Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma. Ann Surg Oncol. 2015 Jul;22(7):2135-42. https://t.co/LHWx7mbYAo.
RT @ProvectusBio: 14/ $PVCT's historical Phase 2 trial was entitled Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma:…
14/ $PVCT's historical Phase 2 trial was entitled Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma: https://t.co/RBBnRgPmbU (2015). #rosebengal #rosebengalsodium
RT @bradpalm1: Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma (July 2015 article) $PVCT https://t.co/dgfWlAcGeq
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma (July 2015 article) $PVCT https://t.co/dgfWlAcGeq
@power4patients have you heard about #PV10 #rosebengal #melanoma http://t.co/YGYjyA3Zup http://t.co/buwVgBXlwO http://t.co/n4jjIthnum
@melanoma_mama have you heard about #PV10 #rosebengal #melanoma http://t.co/YGYjyA3Zup http://t.co/buwVgBXlwO http://t.co/n4jjIthnum
@mrsgkr have you heard about #PV10 #rosebengal #melanoma http://t.co/YGYjyA3Zup http://t.co/buwVgBXlwO http://t.co/n4jjIthnum
OPEN ACCESS: Chemotherapy for Surgically Resected Intrahepatic #Cholangiocarcinoma. http://t.co/ZMy9YaDwHT http://t.co/pbTBPpBrfz
OPEN ACCESS: Chemotherapy for Surgically Resected Intrahepatic #Cholangiocarcinoma. http://t.co/ZMy9YaDwHT http://t.co/pbTBPpBrfz
OPEN ACCESS: Chemotherapy for Surgically Resected Intrahepatic #Cholangiocarcinoma. http://t.co/ZMy9YaDwHT http://t.co/pbTBPpBrfz
@jeanie93 @Ablate_Cancer $MRK trial CRs: #keytruda 5% & #yervoy 1.4% vs.#pv10 ITT Pop @26% stage 3&4 #melanoma http://t.co/OynSh7gjUx
@jeanie93 @Ablate_Cancer $MRK trial CRs: #keytruda 5% & #yervoy 1.4% vs.#pv10 ITT Pop @26% stage 3&4 #melanoma http://t.co/OynSh7gjUx
@jeanie93 @Ablate_Cancer $MRK trial CRs: #keytruda 5% & #yervoy 1.4% vs.#pv10 ITT Pop @26% stage 3&4 #melanoma http://t.co/OynSh7gjUx
@jeanie93 @Ablate_Cancer $MRK trial CRs: #keytruda 5% & #yervoy 1.4% vs.#pv10 ITT Pop @26% stage 3&4 #melanoma http://t.co/OynSh7gjUx
@matthewherper @KingCourt3 $PVCT's #pv10 w/all melanoma injected @<optimal dose= 50% CompleteR, 82% disease control! http://t.co/OynSh7gjUx
@matthewherper @KingCourt3 $PVCT's #pv10 w/all melanoma injected @<optimal dose= 50% CompleteR, 82% disease control! http://t.co/OynSh7gjUx
OPEN ACCESS: Intralesional PV-10 in Refractory Metastatic Melanoma. http://t.co/ljwkBjYCvg http://t.co/Br4fzopIzT
Conclusions: Intralesional PV-10 yielded durable local control with high rates of complete response #melanoma $pvct http://t.co/zhOjdWzLXs
Conclusions: Intralesional PV-10 yielded durable local control with high rates of complete response #melanoma $pvct http://t.co/zhOjdWzLXs
Conclusions: Intralesional PV-10 yielded durable local control with high rates of complete response #melanoma $pvct http://t.co/zhOjdWzLXs
Conclusions: Intralesional PV-10 yielded durable local control with high rates of complete response #melanoma $pvct http://t.co/zhOjdWzLXs
Conclusions: Intralesional PV-10 yielded durable local control with high rates of complete response #melanoma $pvct http://t.co/zhOjdWzLXs
$PVCT http://t.co/9mXxJdfjOJ
$PVCT http://t.co/9mXxJdfjOJ
OPEN ACCESS: Intralesional PV-10 in Refractory Metastatic Melanoma. http://t.co/ljwkBjYCvg http://t.co/Br4fzopIzT
OPEN ACCESS: Intralesional PV-10 in Refractory Metastatic Melanoma. http://t.co/ljwkBjYCvg http://t.co/Br4fzopIzT
OPEN ACCESS: Intralesional PV-10 in Refractory Metastatic Melanoma. http://t.co/DipzPXc25S $PVCT #cancer #provectus
OPEN ACCESS: Intralesional PV-10 in Refractory Metastatic Melanoma. http://t.co/DipzPXc25S $PVCT #cancer #provectus
OPEN ACCESS: Intralesional PV-10 in Refractory Metastatic Melanoma. http://t.co/ljwkBjYCvg http://t.co/Br4fzopIzT
OPEN ACCESS: Intralesional PV-10 in Refractory Metastatic Melanoma. http://t.co/ljwkBjYCvg http://t.co/Br4fzopIzT
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma http://t.co/dR8Aio6UJS
Investigational Agent For Metastatic Melanoma Shows Rapid Complete Responses In High Proportion Of Patients http://t.co/8pBvBJ9igd
Investigational Agent For Metastatic Melanoma Shows Rapid Complete Responses In High Proportion Of Patients http://t.co/8pBvBJ9igd